COMT inhibition with tolcapone does not affect carbidopa pharmacokinetics in parkinsonian patients in levodopa/carbidopa (Sinemet). (Q36053708)
Jump to navigation
Jump to search
scientific article
- COMT inhibition with tolcapone does not affect carbidopa pharmacokinetics in parkinsonian patients in levodopa/carbidopa (Sinemet®)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | COMT inhibition with tolcapone does not affect carbidopa pharmacokinetics in parkinsonian patients in levodopa/carbidopa (Sinemet). |
scientific article |
|
Statements
1 reference
COMT inhibition with tolcapone does not affect carbidopa pharmacokinetics in parkinsonian patients in levodopa/carbidopa (Sinemet). (English)
1 reference
K M Jorga
1 reference
D J Nicholl
1 reference
1 September 1999
1 reference
1 reference
449-452
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference